Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 15, 2005 - Issue 9
Submit an article Journal homepage
32
Views
13
CrossRef citations to date
0
Altmetric
Review

Inhibitors of Aurora kinases for the treatment of cancer

Daniele Fancelli Nerviano Medical Sciences, BU-Oncology, Viale Pasteur, 10, 20014 Nerviano (MI), Italy
&
Jürgen Moll Nerviano Medical Sciences, BU-Oncology, Viale Pasteur, 10, 20014 Nerviano (MI), Italy
Pages 1169-1182 | Published online: 02 Dec 2005

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Paola Vianello. (2007) Aminopyridines: selective AuroraA inhibitors. Expert Opinion on Therapeutic Patents 17:2, pages 255-261.
Read now
Daniele Fancelli. (2006) Compounds and methods for inhibiting mitotic progression. Expert Opinion on Therapeutic Patents 16:8, pages 1179-1182.
Read now

Articles from other publishers (11)

Rakesh Sahu, Kamal Shah, Yash Gautam & Kaushilya Sahu. (2023) Pyrazine Moiety: Recent Developments in Cancer Treatment. Current Organic Chemistry 27:10, pages 821-843.
Crossref
Mandeep Singh, Lakshay Malhotra, Md Anzarul Haque, Mukesh Kumar, Alexander Tikhomirov, Valeria Litvinova, Alexander M. Korolev, A.S. Ethayathulla, Uddipan Das, Andrey E. Shchekotikhin & Punit Kaur. (2021) Heteroarene-fused anthraquinone derivatives as potential modulators for human aurora kinase B. Biochimie 182, pages 152-165.
Crossref
Tao Yu, Yonglian Zhang, Angela D. Kerekes, Jayaram R. Tagat, Ronald J. Doll, Yushi Xiao, Sara Esposite, Alan Hruza, David B. Belanger, Matthew Voss, Matthew P. Rainka, Andrea Basso, Ming Liu, Lianzhu Liang, Ning Sui, Daniel Prelusky, Diane Rindgen & Likang Zhang. (2018) Discovery of a highly potent orally bioavailable imidazo-[1, 2- a ]pyrazine Aurora inhibitor. Bioorganic & Medicinal Chemistry Letters 28:8, pages 1397-1403.
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2015. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs 391 491 .
Zhiqin Ji, Yujia Dai, Cele Abad-Zapatero, Daniel H. Albert, Jennifer J. Bouska, Keith B. Glaser, Patrick A. Marcotte, Nirupama B. Soni, Terry J. Magoc, Kent D. Stewart, Ru-Qi Wei, Steve K. Davidsen & Michael R. Michaelides. (2012) Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 22:14, pages 4528-4531.
Crossref
Mm Neaz, M Muddassar, Fa Pasha & Seung Joo Cho. (2010) Structural studies of B-type Aurora kinase inhibitors using computational methods. Acta Pharmacologica Sinica 31:2, pages 244-258.
Crossref
Hui-Yuan Wang, Lin-Li Li, Zhi-Xing Cao, Shi-Dong Luo, Yu-Quan Wei & Sheng-Yong Yang. (2009) A Specific Pharmacophore Model of Aurora B Kinase Inhibitors and Virtual Screening Studies Based on it. Chemical Biology & Drug Design 73:1, pages 115-126.
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2008. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs 251 305 .
Patrizia Carpinelli & Jürgen Moll. 2008. Targeted Therapies in Cancer. Targeted Therapies in Cancer 54 73 .
Francesco Colotta. 2008. Targeted Therapies in Cancer. Targeted Therapies in Cancer 19 42 .
Andrew A. Mortlock, Kevin M. Foote, Nicola M. Heron, Frédéric H. Jung, Georges Pasquet, Jean-Jacques M. Lohmann, Nicolas Warin, Fabrice Renaud, Chris De Savi, Nicola J. Roberts, Trevor Johnson, Cyril B. Dousson, George B. Hill, David Perkins, Glenn Hatter, Robert W. Wilkinson, Stephen R. Wedge, Simon P. Heaton, Rajesh Odedra, Nicholas J. Keen, Claire Crafter, Elaine Brown, Katherine Thompson, Stephen Brightwell, Liz Khatri, Madeleine C. Brady, Sarah Kearney, David McKillop, Steve Rhead, Tony Parry & Stephen Green. (2007) Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase . Journal of Medicinal Chemistry 50:9, pages 2213-2224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.